A virtual summit and recent reports from various outlets are discussing the latest developments in treating bladder cancer. Experts are highlighting new approaches and key data from the 2026 ASCO event, including updates on urothelial carcinoma and muscle-invasive bladder cancer. The reports suggest that there may be improved survival rates for certain types of bladder and kidney cancer, but the specifics and outcomes are not entirely clear.